Clinical Trial Update: Oxaliplatin, Capecitabine, and Radiation Therapy in Patients Undergoing Surgery for Stage II, III, IV Esophageal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial results for oxaliplatin, capecitabine, and radiation therapy in patients undergoing surgery for stage II-IV esophageal cancer have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• Eloxatin (oxaliplatin)
• Xeloda (capecitabine)

Snippet

Sponsor: Roswell Park Cancer Institute | Conditions: Esophageal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2013-11-25